Clinical trial
Associations Between Drug Levels and the Risk of Malaria and Drug Resistance in the Setting of Seasonal Malaria Chemoprevention in Bobo-Dioulasso, Burkina Faso
NCT04969185 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Associations Between Drug Levels and the Risk of Malaria and Drug Resistance in the Setting of Seasonal Malaria Chemoprevention in Bobo-Dioulasso, Burkina Faso
- Lead sponsor
- University of California, San Francisco
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 16, 2021
- Completion date
- May 23, 2023
- Enrollment
- 310 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
malaria,falciparum